These results are consistent with a previous study [32]: Jiawu Wang indicated most of the m6A regulators have different expressions in RCC tissue, and METTL14 and METTL3 were identified as two powerful independent prognostic regulators after further analysis. The gene discussed is METTL3; the disease is renal cell carcinoma.